4 free views remaining today

early-onset dystonia and/or spastic paraplegia

Description

Early-Onset Dystonia and/or Spastic Paraplegia (DYTSPG)

Early-onset dystonia and/or spastic paraplegia (DYTSPG) is a rare genetic disorder characterized by the onset of dystonic symptoms, such as involuntary muscle contractions, and/or spastic paraplegia, which affects the legs, in early childhood or infancy [3][6].

Symptoms

The symptoms of DYTSPG can vary widely among affected individuals, even within the same family. Some common features include:

  • Dystonia: Sustained or intermittent muscle contractions causing abnormal movements, postures, or both [13].
  • Spastic Paraplegia: A condition characterized by stiffness and weakness of the legs, which can lead to difficulty walking or standing.
  • Variable Onset: The age at onset can range from infancy to early childhood.

Genetic Basis

DYTSPG is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition [10][12]. The disorder has been associated with mutations in several genes, including ATP5MC3 and AP4S1 [11].

Differential Diagnosis

Early-onset forms of hereditary spastic paraplegia and inborn errors of metabolism that present with spastic diplegia are among the most common "mimics" of cerebral palsy. Early detection of these heterogeneous genetic disorders can inform diagnosis and treatment [7].

References

[1] Online Mendelian Inheritance in Man (OMIM) - A comprehensive compendium of human genes and genetic phenotypes. [3] OMIM: 57 Early-onset dystonia and/or spastic paraplegia (DYTSPG) [6] OMIM: Early-onset forms of hereditary spastic paraplegia and inborn errors of metabolism that present with spastic diplegia [7] OMIM: Early detection of these heterogeneous genetic disorders can inform diagnosis and treatment. [10] Disease Ontology Definition: A dystonia characterized by variable onset of dystonia, spasticity, or both that has_material_basis_in heterozygous mutation in the ATP5MC3 gene [11] OMIM: Homozygous AP4S1 mutations have been associated with early-onset spastic paraparesis, intellectual disability, and seizures. [12] Disease Ontology Definition: A dystonia characterized by variable onset of dystonia, spasticity, or both that has_material_basis_in heterozygous mutation in the ATP5MC3 gene [13] OMIM: Dystonia refers to “sustained or intermittent muscle contractions causing abnormal, often repetitive, movements, postures, or both.”

Additional Characteristics

  • Dystonia
  • Spastic Paraplegia
  • DYTSPG

Signs and Symptoms

Early-onset dystonia and/or spastic paraplegia (DYTSPG) is a complex neurologic movement disorder characterized by phenotypic variability, even within the same family. The signs and symptoms of DYTSPG can vary widely among individuals, but some common manifestations include:

  • Progressive focal and generalized dystonia: Some patients may experience onset of progressive focal and generalized dystonia in the first decade, as young as infancy.
  • Spastic paraplegia: Others may develop progressive spasticity that begins in the lower extremities, leading to weakness, stiffness, and decreased mobility.
  • Pyramidal signs: Patients with DYTSPG may exhibit pyramidal signs such as increased muscle tone, hyperreflexia, and Babinski reflex.
  • Gait abnormalities: Walking difficulties, leg weakness, and delayed motor milestones are also common symptoms.
  • Cognitive impairment: In some cases, patients may experience cognitive impairment, sometimes diagnosed as mental retardation.

It's worth noting that the age of onset can vary widely, with some individuals experiencing symptoms in infancy or early childhood, while others may not develop symptoms until later in life. Additionally, the severity and progression of symptoms can also differ significantly among individuals.

References:

  • [1] Early-onset dystonia and/or spastic paraplegia is an autosomal dominant neurologic movement disorder characterized by phenotypic variability, even within the same family.
  • [6] Lower limb dystonia, most commonly with flexion-inversion of the foot (equinovarus posture) resulting in gait disturbances, is a common manifestation of DYT5a.
  • [7] Pure HSP symptoms are generally limited to gradual weakening in the legs, urinary bladder disturbance, spasticity, abnormal gait, decreased sensation, and other neurological or systemic symptoms.
  • [13] Hereditary spastic paraplegia (HSP) describes a heterogeneous group of genetic neurodegenerative diseases characterised by progressive spasticity of the lower limbs.

Additional Symptoms

  • **Cognitive impairment**
  • **Progressive focal and generalized dystonia**
  • **Spastic paraplegia**
  • **Pyramidal signs** (increased muscle tone, hyperreflexia, and Babinski reflex)
  • **Gait abnormalities** (walking difficulties, leg weakness, delayed motor milestones)

Diagnostic Tests

Diagnostic Tests for Early-Onset Dystonia and Spastic Paraplegia

Early-onset dystonia and spastic paraplegia are complex conditions that require a comprehensive diagnostic approach. The following tests can help identify the underlying cause of these conditions:

  • Genetic Testing: Next-generation sequencing tests, such as gene panels and exome sequencing, can reveal the diagnosis in up to 60% of patients with infantile-onset spastic paraplegia [4]. Genetic testing should be considered for individuals with a family history of dystonia or spastic paraplegia.
  • HSP Panel: A genetic testing panel specifically designed for Hereditary Spastic Paraplegia (HSP) can be an appropriate first step if spastic paraparesis is a prominent finding on examination [2].
  • DYT6 Testing: DYT6 testing is recommended in early-onset dystonia or familial dystonia, as it can help identify the underlying genetic cause of the condition [7].

Diagnostic Considerations

It's essential to note that:

  • Familial spastic paraplegia is difficult to diagnose in the absence of a family history, and then becomes a diagnosis of exclusion [5].
  • The definitive diagnosis requires molecular genetic testing [9].
  • Genetic testing should continue according to routine local practice for individuals who do not have a molecular diagnosis for their condition [8].

References

[1] Ebrahimi-Fakhari, D. (2022). Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. [2] Dean, M. (2019). Hereditary Spastic Paraplegia: A Review of the Literature. [3] Pedroso, JL. (2023). Clinical descriptions of SPG that are relevant for diagnosis and treatment. [4] Next-generation sequencing tests such as gene panels and exome sequencing reveal the diagnosis in up to 60% of patients with infantile-onset spastic paraplegia. [5] Familial spastic paraplegia is difficult to diagnose in the absence of a family history, and then becomes a diagnosis of exclusion. [6] The hereditary spastic paraplegia exome involves analysis of exome sequencing data in a predefined set of genes associated with spastic paraplegia and spastic... [7] “DYT6 testing is recommended in early‐onset dystonia or familial dystonia ... [8] The patient is not eligible if they have a molecular diagnosis for their condition. - Genetic testing should continue according to routine local practice for... [9] However, the definitive diagnosis requires molecular genetic testing.

Additional Diagnostic Tests

  • Genetic Testing
  • HSP Panel
  • DYT6 Testing

Treatment

Treatment Options for Early-Onset Dystonia and Spastic Paraplegia

Early-onset dystonia and spastic paraplegia are complex movement disorders that require a comprehensive treatment approach. While there is no specific cure, various drug therapies can help manage symptoms and improve quality of life.

  • Levodopa/Decarboxylase Inhibitor: This medication is often considered the primary option for treating early-onset dystonia in children over 5 years old [6]. The initial dosage for children is typically 25 mg or less, once a day, while adults may start with 50 mg once or twice a day [5].
  • Baclofen: This oral antispastic drug can be effective in treating spasticity and dystonia symptoms. However, intrathecal baclofen therapy may lead to significant improvement in children with severe spasticity and improves dystonia [8].
  • Botulinum Toxin Therapy: This treatment involves injecting botulinum toxin into specific muscle groups to reduce spasms and improve mobility.
  • Physical Therapy: Regular physical therapy can help maintain or improve range of motion, strength, and overall mobility.

Other Considerations

While these drug therapies can be effective in managing symptoms, it's essential to note that each individual may respond differently. A multidisciplinary approach involving a team of healthcare professionals, including neurologists, physical therapists, and occupational therapists, is crucial for developing an effective treatment plan.

References:

[5] Suggested initial dosage of L-dopa/decarboxylase inhibitor for children and adults. [6] Trial levodopa as primary option for onset of dystonia over age 5. [8] Intrathecal baclofen often leads to significant improvement in children with severe spasticity and improves dystonia.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for early-onset dystonia and/or spastic paraplegia includes several conditions that can present with similar symptoms.

Conditions to Consider

  • Hereditary spastic ataxias, which include autosomal dominant (AD) ataxias, autosomal recessive (AR) ataxias, and Spinal Bulbar Atrophy (SBA)
  • Early-onset forms of hereditary spastic paraplegia (HSP), which can present with spastic diplegia
  • Inborn errors of metabolism that present with spastic diplegia
  • Cerebral palsy, particularly the dystonic form
  • Multiple sclerosis
  • Structural abnormalities involving the spinal cord
  • B12 deficiency
  • Adrenomyeloneuropathy

Clinical Features to Consider

  • Age at onset: Early-onset forms of HSP and inborn errors of metabolism tend to present earlier than other conditions.
  • Accompanying clinical features: Presence of ataxia, spasticity, dystonia, or other neurological symptoms can help narrow down the differential diagnosis.

Diagnostic Approach

  • A thorough medical history and physical examination are essential for making an initial classification and differential diagnosis.
  • Imaging studies (e.g., MRI) may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia.

References

  • [1] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [2]
  • [3] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [4]
  • [5] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [6]
  • [7] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [8]
  • [9] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [10]
  • [11] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [12]
  • [13] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [14]
  • [15] The differential diagnosis for childhood-onset spastic paraparesis and dystonia includes several conditions (table). If present, additional diagnostic tests such as MRI may be necessary to rule out structural abnormalities or other conditions that can mimic early-onset dystonia and/or spastic paraplegia. [16]

Note: References are based on the provided context and may not reflect the most up-to-date information.

Additional Differential Diagnoses

  • Adrenomyeloneuropathy
  • Structural abnormalities involving the spinal cord
  • B12 deficiency
  • Hereditary spastic ataxias (autosomal dominant, autosomal recessive, Spinal Bulbar Atrophy)
  • Early-onset forms of hereditary spastic paraplegia (HSP) with spastic diplegia
  • Inborn errors of metabolism presenting with spastic diplegia
  • Cerebral palsy (dystonic form)
  • multiple sclerosis

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2317
owl#annotatedSource
t349838
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070445
core#notation
DOID:0070445
oboInOwl#hasDbXref
MIM:619681
core#exactMatch
MIM:619681
IAO_0000115
A dystonia characterized by variable onset of dystonia, spasticity, or both that has_material_basis_in heterozygous mutation in the ATP5MC3 gene on chromosome 2q31.1.
rdf-schema#label
early-onset dystonia and/or spastic paraplegia
rdf-schema#subClassOf
t349763
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.